In bear markets, we move into defensives like Pharma and FMCG. Moreover, a lot more emphasis is given on stocks rather than top-down approach. This helps the fund contain erosion of its value. Does the fund's focus on diversification hamper its growth in buoyant market conditions? What are the prospects for FMCG and healthcare sectors? What kind of a strategy would you recommend in the present stock market conditions? |